BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36599133)

  • 21. Docosahexaenoic acid (DHA), a primary tumor suppressive omega-3 fatty acid, inhibits growth of colorectal cancer independent of p53 mutational status.
    Kato T; Kolenic N; Pardini RS
    Nutr Cancer; 2007; 58(2):178-87. PubMed ID: 17640164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histone Acetyltransferases p300 and CBP Coordinate Distinct Chromatin Remodeling Programs in Vascular Smooth Muscle Plasticity.
    Chakraborty R; Ostriker AC; Xie Y; Dave JM; Gamez-Mendez A; Chatterjee P; Abu Y; Valentine J; Lezon-Geyda K; Greif DM; Schulz VP; Gallagher PG; Sessa WC; Hwa J; Martin KA
    Circulation; 2022 Jun; 145(23):1720-1737. PubMed ID: 35502657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases.
    Barlev NA; Liu L; Chehab NH; Mansfield K; Harris KG; Halazonetis TD; Berger SL
    Mol Cell; 2001 Dec; 8(6):1243-54. PubMed ID: 11779500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rubinstein-Taybi Syndrome and Epigenetic Alterations.
    Korzus E
    Adv Exp Med Biol; 2017; 978():39-62. PubMed ID: 28523540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenovirus E1A Activation Domain Regulates H3 Acetylation Affecting Varied Steps in Transcription at Different Viral Promoters.
    Hsu E; Pennella MA; Zemke NR; Eng C; Berk AJ
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acetylation dynamics of human nuclear proteins during the ionizing radiation-induced DNA damage response.
    Bennetzen MV; Larsen DH; Dinant C; Watanabe S; Bartek J; Lukas J; Andersen JS
    Cell Cycle; 2013 Jun; 12(11):1688-95. PubMed ID: 23656789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein-Taybi syndrome.
    Lopez-Atalaya JP; Gervasini C; Mottadelli F; Spena S; Piccione M; Scarano G; Selicorni A; Barco A; Larizza L
    J Med Genet; 2012 Jan; 49(1):66-74. PubMed ID: 21984751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CREBBP mutations in relapsed acute lymphoblastic leukaemia.
    Mullighan CG; Zhang J; Kasper LH; Lerach S; Payne-Turner D; Phillips LA; Heatley SL; Holmfeldt L; Collins-Underwood JR; Ma J; Buetow KH; Pui CH; Baker SD; Brindle PK; Downing JR
    Nature; 2011 Mar; 471(7337):235-9. PubMed ID: 21390130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is histone acetylation the most important physiological function for CBP and p300?
    Bedford DC; Brindle PK
    Aging (Albany NY); 2012 Apr; 4(4):247-55. PubMed ID: 22511639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human immunodeficiency virus type-1 Tat/co-activator acetyltransferase interactions inhibit p53Lys-320 acetylation and p53-responsive transcription.
    Harrod R; Nacsa J; Van Lint C; Hansen J; Karpova T; McNally J; Franchini G
    J Biol Chem; 2003 Apr; 278(14):12310-8. PubMed ID: 12501250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential contribution of p300 and CBP to regulatory element acetylation in mESCs.
    Martire S; Nguyen J; Sundaresan A; Banaszynski LA
    BMC Mol Cell Biol; 2020 Jul; 21(1):55. PubMed ID: 32690000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resveratrol modulates epigenetic regulators of promoter histone methylation and acetylation that restores BRCA1, p53, p21
    Chatterjee B; Ghosh K; Kanade SR
    Biofactors; 2019 Sep; 45(5):818-829. PubMed ID: 31317586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural insight into the recognition of acetylated histone H3K56ac mediated by the bromodomain of CREB-binding protein.
    Xu L; Cheng A; Huang M; Zhang J; Jiang Y; Wang C; Li F; Bao H; Gao J; Wang N; Liu J; Wu J; Wong CCL; Ruan K
    FEBS J; 2017 Oct; 284(20):3422-3436. PubMed ID: 28815970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutation of chromatin modifiers; an emerging hallmark of germinal center B-cell lymphomas.
    Lunning MA; Green MR
    Blood Cancer J; 2015 Oct; 5(10):e361. PubMed ID: 26473533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy.
    Cerchietti LC; Hatzi K; Caldas-Lopes E; Yang SN; Figueroa ME; Morin RD; Hirst M; Mendez L; Shaknovich R; Cole PA; Bhalla K; Gascoyne RD; Marra M; Chiosis G; Melnick A
    J Clin Invest; 2010 Dec; 120(12):4569-82. PubMed ID: 21041953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SIAH-mediated ubiquitination and degradation of acetyl-transferases regulate the p53 response and protein acetylation.
    Grishina I; Debus K; García-Limones C; Schneider C; Shresta A; García C; Calzado MA; Schmitz ML
    Biochim Biophys Acta; 2012 Dec; 1823(12):2287-96. PubMed ID: 23044042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histone modifications affect differential regulation of TGFβ- induced NADPH oxidase 4 (NOX4) by wild-type and mutant p53.
    Boudreau HE; Ma WF; Korzeniowska A; Park JJ; Bhagwat MA; Leto TL
    Oncotarget; 2017 Jul; 8(27):44379-44397. PubMed ID: 28574838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription.
    Balasubramanyam K; Varier RA; Altaf M; Swaminathan V; Siddappa NB; Ranga U; Kundu TK
    J Biol Chem; 2004 Dec; 279(49):51163-71. PubMed ID: 15383533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic histone acetylation/deacetylation with progesterone receptor-mediated transcription.
    Aoyagi S; Archer TK
    Mol Endocrinol; 2007 Apr; 21(4):843-56. PubMed ID: 17227884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma.
    Chen J; Xu-Monette ZY; Deng L; Shen Q; Manyam GC; Martinez-Lopez A; Zhang L; Montes-Moreno S; Visco C; Tzankov A; Yin L; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Zhao X; Møller MB; Farnen JP; Winter JN; Piris MA; Pham L; Young KH
    Oncotarget; 2015 Mar; 6(8):5597-614. PubMed ID: 25704881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.